Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,073 total articles
Ocular Therapeutix, a biopharmaceutical company specializing in retinal diseases, announced its scheduled presentations at Clinical Trials at the Summit 2026. The company will share updates on its Phase 3 clinical trials of AXPAXLI (OTX-TKI), an investigational treatment targeting wet age-related macular degeneration and diabetic retinal diseases. …
Tilray Brands' subsidiary, Breckenridge Distillery, has introduced Breckenridge Rye Whiskey, a bold and richly flavored 100 proof rye whiskey crafted at 9,600 feet in Colorado. This new product builds on the distillery's reputation for quality and innovation and will be available in Colorado now and nationally in summer 2026.
Regeneron Pharmaceuticals announced upcoming presentations at the 2026 ADA and ENDO meetings highlighting new clinical and preclinical data from their metabolic disease, ophthalmology, and rare disease drug pipelines. Key focus includes the Phase 2 COURAGE trial on muscle and metabolic health, early data on Graves' and thyroid eye disease, and pivo…
LeonaBio, a clinical-stage biopharmaceutical company, presented its ALS drug candidate brelgometon (ATH-1105) at the 5th Annual ALS Drug Development Summit. The presentation highlighted the oral, brain-penetrant drug's mechanism and supporting Phase 1 and preclinical data. LeonaBio plans to initiate a randomized, placebo-controlled Phase 2 proof-of…
REalloys Inc., a U.S.-based mine-to-magnet rare earth company, signed a non-binding Letter of Intent with Patriot Exploration & Mining, a U.S. rare earth exploration firm with access to 2 billion metric tons of rare earth material across the Appalachian Basin. The agreement establishes a framework for REalloys to obtain priority access to up to 30%…
GH Research PLC reported successful Phase 2a trial results for inhaled mebufotenin (GH001) in treating postpartum depression, with 100% remission within two hours sustained through 8 days. The treatment was well-tolerated with minimal side effects and only brief breastfeeding interruption. The company also announced upcoming presentations on Phase …
Click Holdings Limited (NASDAQ: CLIK), a leader in AI-powered human resources and senior care solutions in Hong Kong, announced a strong Q3 financial performance with a 73% year-over-year increase in revenue to HK$38 million. Growth was driven by higher demand for premium nursing and elderly care services, alongside expanded logistics capacity. The…
Parsons Corporation highlights its expanding AI capabilities integrated into Federal Solutions and Critical Infrastructure segments, driving growth through advanced, scalable AI-enabled applications in national security and infrastructure. The company emphasizes AI's critical role in winning major contracts, improving mission outcomes, and optimizi…
Akamai Technologies announces Workspot as a new independent software vendor partner in its Qualified Compute Partner Program. This partnership enables customers to migrate from legacy VDI systems to Akamai Cloud PC—a high-performance, secure desktop-as-a-service solution leveraging Akamai's global cloud and low-latency network. Workspot's cloud nat…
InterPrivate Investment Partners V, Inc., a blank check company focused on effecting mergers or acquisitions, priced its initial public offering of 17.5 million units at $10 per unit, raising $175 million. Units will trade on Nasdaq under ticker IPVVU, with underlying shares and warrants trading separately under IPVV and IPVVW. The company aims to …
Auddia Inc. announced the initiation of development milestones for its AI-native, Web3-enabled McCarthy Finney Operating System (MCFN-OS), marking progress before its planned merger with Thramann Holdings. The merger will rebrand Auddia as McCarthy Finney (ticker MCFN) and expand its AI and Web3 portfolio across multiple subsidiaries targeting sect…
GRAVITY Co., Ltd., a Nasdaq-listed game developer, announced the official launch of their mobile game Ragnarok: Twilight Global in Europe and the Americas. The game, an idle MMORPG, has already achieved strong performance in Asian markets and now targets wider global audiences through app stores and official channels. The launch follows a thorough …
X-energy, Inc. (NASDAQ: XE) announced its first quarter 2026 financial results and operational milestones, highlighting a 109% increase in revenues and grant income to $43 million. The company successfully raised $1.1 billion net proceeds through its recent IPO and began trading on Nasdaq. Key achievements include regulatory progress such as NRC's …
DHT Holdings, an independent crude oil tanker company, announced a new $250 million reducing revolving credit facility with a seven-year tenor and attractive terms. The facility enhances the company’s financial flexibility by extending its debt maturity profile and optimizing its capital structure. The credit arrangement is supported by a strong sy…
GEN Restaurant Group, operator of GEN Korean BBQ, announced a new distribution agreement with C&S Wholesale Grocers, enabling GEN to expand its ready-to-cook marinated meat products through one of the largest wholesale grocery networks in the U.S. This partnership aims to scale GEN's consumer packaged goods business and increase brand accessibility…
FTI Consulting released its 2026 Private Equity Value Creation Index, revealing that AI is significantly accelerating value creation timelines in private equity, while M&A has become the top value driver despite slower execution. The survey shows private equity firms achieve faster results overall, with AI delivering benefits within 12 months for 6…
Sportradar Group AG announced a multi-year extension of its exclusive data and audiovisual betting rights agreement with the All England Club for The Championships, Wimbledon. This deal, part of Sportradar's acquisition of IMG ARENA, strengthens its position in global tennis data distribution, covering three of the four Grand Slams and expanding in…
Royal Philips and WellSpan Health announce a landmark seven-year strategic alliance that will enhance diagnostics and imaging technology deployment in WellSpan’s facilities. This collaboration integrates research, innovation, and a commercial agreement positioning WellSpan as a leading community health system in AI-enabled care, improving operation…
Alvotech announced the resubmission of its Biologics License Applications to the FDA for AVT05 and AVT06, proposed biosimilars to Johnson & Johnson's Simponi products and Regeneron's Eylea respectively. This follows responses to the FDA's Post-Application Action Letter and cGMP inspections at their Reykjavik facility. The company expects a six-mont…
Magnite, the largest independent sell-side advertising company listed on Nasdaq (MGNI), announced an expanded partnership with JioHotstar, India’s biggest premium entertainment streaming service. The collaboration focuses on leveraging Magnite's SpringServe mediation technology to optimize programmatic ad inventory across JioHotstar’s live sports a…
Biogen Inc. and UCB presented Phase 3 PHOENYCS GO study data demonstrating that dapirolizumab pegol combined with standard care provides sustained disease control in systemic lupus erythematosus (SLE) patients while allowing significant reduction in glucocorticoid steroid use through 48 weeks. Additional findings include improved immunological mark…
WISeSat.Space Corp., a subsidiary of WISeKey International Holding Ltd., has confidentially submitted an amended draft registration statement on Form F-4 to the SEC related to its proposed business combination with Columbus Acquisition Corp (Nasdaq: COLA), a SPAC. Upon closing, the combined company will trade on Nasdaq under the ticker WSAT. WISeSa…
Pharming Group announced that the U.S. FDA has accepted the resubmission of the supplemental New Drug Application for Joenja (leniolisib) to extend approval for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). If approved, Joenja will be the first treatment available in the U.S. for this rare pediatric imm…
Jade Biosciences, a clinical-stage biotech company focused on autoimmune therapies, announced the pricing of a $150 million public offering of 10 million shares to advance its clinical and preclinical programs. The proceeds will fund clinical trials, manufacturing, R&D, capital spends, and general corporate purposes. The offering is expected to clo…
3D Systems Corporation announced the pricing of an upsized underwritten public offering of approximately 16.4 million shares at $3.05 per share, raising about $50 million in gross proceeds. The offering is expected to close on June 5, 2026, with an option for underwriters to purchase additional shares. The funds will support the company's initiativ…
